Aptevo Therapeutics Inc. Quarterly Current Ratio in % from Q1 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Aptevo Therapeutics Inc. quarterly Current Ratio history and growth rate from Q1 2017 to Q3 2024.
  • Aptevo Therapeutics Inc. Current Ratio for the quarter ending September 30, 2024 was 204 %, a 42.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 204 -149 -42.1% Sep 30, 2024
Q2 2024 240 -114 -32.1% Jun 30, 2024
Q1 2024 275 -107 -28.1% Mar 31, 2024
Q4 2023 341 +77 +29.1% Dec 31, 2023
Q3 2023 353 +148 +72.5% Sep 30, 2023
Q2 2023 354 +165 +87.8% Jun 30, 2023
Q1 2023 382 +203 +113% Mar 31, 2023
Q4 2022 264 +75.8 +40.2% Dec 31, 2022
Q3 2022 205 -14.4 -6.59% Sep 30, 2022
Q2 2022 188 -63.1 -25.1% Jun 30, 2022
Q1 2022 180 -79.8 -30.8% Mar 31, 2022
Q4 2021 189 -98.6 -34.3% Dec 31, 2021
Q3 2021 219 +75 +52.1% Sep 30, 2021
Q2 2021 251 +148 +144% Jun 30, 2021
Q1 2021 259 +133 +105% Mar 31, 2021
Q4 2020 287 +135 +88.5% Dec 31, 2020
Q3 2020 144 -64 -30.8% Sep 30, 2020
Q2 2020 103 -207 -66.8% Jun 30, 2020
Q1 2020 126 -209 -62.3% Mar 31, 2020
Q4 2019 152 -217 -58.7% Dec 31, 2019
Q3 2019 208 -223 -51.7% Sep 30, 2019
Q2 2019 310 -205 -39.8% Jun 30, 2019
Q1 2019 335 -232 -40.9% Mar 31, 2019
Q4 2018 369 -225 -37.9% Dec 31, 2018
Q3 2018 431 -114 -20.9% Sep 30, 2018
Q2 2018 515 +31.2 +6.46% Jun 30, 2018
Q1 2018 567 +163 +40.2% Mar 31, 2018
Q4 2017 594 Dec 31, 2017
Q3 2017 545 Sep 30, 2017
Q2 2017 483 Jun 30, 2017
Q1 2017 405 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.